| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | MI 1d-1 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-2 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-3 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-4 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-5 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-6 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-7 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-8 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 1d-9 | Sample source:Spleen | treatment:MI1d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-1 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-2 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-3 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-4 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-5 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-6 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-7 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-8 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | MI 3d-9 | Sample source:Spleen | treatment:MI 3d | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-1 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-2 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-3 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-4 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-5 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-6 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-7 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-8 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
| Reversed phase NEGATIVE ION MODE | Sham-9 | Sample source:Spleen | treatment:Sham | ng/mg of tissue |
Return to study ST003244 main page
Download data matrix(Suppression of prostaglandin I2–type I interferon axis induces extramedullary hematopoiesis to promote cardiac repair after myocardial infarction Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|